An Innovative Dosage Form on Naltrexone, a new option for opioid addiction anti- relapse treatment

Title : An Innovative Dosage Form on Naltrexone, a new option for opioid addiction anti- relapse treatment

Abstract:

The introduction of Sciencare naltrexone implant is used to effectively block dependence on opioids and assist in the treatment of alcohol dependence.

Sciencare has a unique patented release technology, which can effectively control the drug release curve and enhance the safety of patients and the effectiveness of treatment.

A new type of sustained-release naltrexone implant with safe, effective, long-acting and controllable characteristics will be a high-value choice for the treatment of opioid addiction and alcohol addiction in the near future.

Biography:

Mr. Kaikai Chen studied Health Services Administration at the University of Detroit Mercy, USA and graduated as MS in 2014. He then joined the Community Health program at the Michigan Association of Chinese Americans. He was mainly committed to cooperating with the Michigan state government on substance abuse prevention and smoking projects in minority communities. Mr. Kaikai Chen then returned to China and joined Sciencare, mainly responsible for Sciencare's international marketing and global cooperation projects.